NASDAQ: APLT
Applied Therapeutics Inc Stock Ownership - Who owns Applied Therapeutics?

Insider buying vs selling

Have Applied Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Stacy J. KanterDirector2025-12-1643,000$0.11
$4.82kSell
Constantine ChinoporosChief Operating Officer and Chief Business Officer2025-03-04447$0.44
$196.68Sell
Leslie D. FuntleyderInterim Chief Executive Officer and Chief Financial Officer2025-03-0414,502$0.44
$6.38kSell
Riccardo PerfettiChief Medical Officer2025-03-0410,366$0.44
$4.56kSell
Leslie D. FuntleyderInterim Chief Executive Officer and Chief Financial Officer2025-02-0622,950$0.61
$14.00kSell
Riccardo PerfettiChief Medical Officer2025-02-0686,078$0.61
$52.51kSell
Constantine ChinoporosChief Operating Officer and Chief Business Officer2025-02-0628,117$0.61
$17.15kSell

1 of 1

APLT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when APLT insiders and whales buy or sell their stock.

APLT Shareholders

What type of owners hold Applied Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
T Rowe Price Investment Management Inc14.83%21,403,300$2.68MInstitution
Vestal Point Capital LP9.88%14,250,000$1.78MInstitution
Propel Bio Management LLC7.82%11,285,420$1.41MInstitution
Knoll Capital Management LLC5.41%7,799,687$974.96kInstitution
Shoshana Shendelman4.19%6,049,953$756.24kInsider
Vanguard Group Inc3.54%5,102,689$637.84kInstitution
Simplify Asset Management Inc3.11%4,487,505$560.94kInstitution
Blackrock Inc2.66%3,843,733$480.47kInstitution
Pnc Financial Services Group Inc2.01%2,901,184$362.65kInstitution
Pathstone Holdings LLC1.83%2,643,540$330.44kInstitution

1 of 3

APLT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
APLT65.67%8.55%Net SellingNet Selling
APVO2.93%21.29%Net BuyingNet Buying
LSTA0.84%99.16%Net Selling
CTXR3.67%3.32%
KAPA2.14%35.55%

Applied Therapeutics Stock Ownership FAQ

Who owns Applied Therapeutics?

Applied Therapeutics (NASDAQ: APLT) is owned by 65.67% institutional shareholders, 8.55% Applied Therapeutics insiders, and 25.78% retail investors. Shoshana Shendelman is the largest individual Applied Therapeutics shareholder, owning 6.05M shares representing 4.19% of the company. Shoshana Shendelman's Applied Therapeutics shares are currently valued at $756.24k.

If you're new to stock investing, here's how to buy Applied Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.